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The human breath contains small droplets generated during the reopening of collapsed terminal airways. The properties of the exhaled aerosols are determined from the conditions in the lung periphery. Therefore, characterization of exhaled particles might be useful for non-invasive diagnosis of lung disease. In this study, the impact of peripheral and central airway obstruction on particle emission characteristics was investigated.
Background
Exhaled aerosol properties were recorded for healthy non-smokers (n = 16), healthy smokers (n = 13), patients with chronic obstructive pulmonary disease (COPD, n = 28, GOLD-stage I -IV), as well as patients with asthma following methacholine challenge (n = 10) in order to assess the influence of airway obstruction on particle emission pattern. Particle number flux was assessed by means of a condensation nucleus counter (TSI 3760), and particle size distribution was determined by a laser spectrometer (PMT LASAIR II-110).
Methods
Airway obstruction did not have an impact on number and size of endogenously generated exhaled particles.
Determination of particle number flux during breath condensate sampling would allow for a normalization procedure to improve the validity of biochemical analysis.
The individual particle emission pattern, which is highly reproducible, serves as a fingerprint of the actual status of the lung. The usefulness of more complex physical parameters of breath aerosols as a biomarker for detection of airway disease is currently investigated (see separate poster J106).
Conclusion
Supported by Deutsche Forschungsgemeinschaft (Ho 2158/1-2).
Results
However, there was a large inter-subject variability of emitted particle number in the order of about two magnitudes, with no influence of airway obstruction on emission level (Fig.2) . Similarly, methacholine-induced airway obstruction in subjects with allergic asthma did not change the exhaled particle number when compared to pre-challenge values, as shown in Figure 3 . 
Figure 4: Particle size distribution at normal tidal volume averaged for all healthy subjects (black curve), COPD-patients (blue curve) and subjects with allergic asthma (red curve). .
For the droplet size distribution averaged per breath, there was no difference between healthy subjects and subjects with airway obstruction (Fig. 4) 
[%pred] N number of subjects in group; FEV1 forced expiratory volume in 1s, FVC forced vital capacity, RV residual volume, TLC total lung capacity, FRC functional residual capacity; FVC*/FEV1* data after lysis for patients with COPD; FEV1** data after methacholine challenge, PC20 = provocative concentration of methacholine causing a 20% fall in FEV1. All data are given as arithmetic mean ± standard deviation.
